International Symposium on Paget's Disease
Oxford, UK
8-9 July 2009

Preceded by 4th International Workshop on Advances in the Molecular Pharmacology and
Therapeutics of Bone Disease
, 6-8 July 2009

About the meeting

It was 1876 when Sir James Paget first described Paget's disease of bone and since that time it has remained a challenging and enigmatic disorder affecting a substantial proportion of the adult population in many countries. In the United Kingdom the National Association for the Relief of Paget's Disease was founded as a medical charity over 30 years ago. Although much new research has been presented at recent meetings there are still many questions that remain unanswered.

Paget's disease can now be effectively treated and many of its distressing and disabling complications prevented. This meeting will bring together international experts to discuss the latest advances in knowledge, with particular emphasis on advances in epidemiology, genetics and treatment.

The meeting will be of interest to doctors from the many disciplines that deal with Paget's disease, as well as to scientists working on research problems related to the disease.
The meeting is approved for CPD.

Scientific Committee

Chairman: Graham Russell (Oxford, UK)
Michael Davie (Oswestry, UK)
Roger Francis (Newcastle-upon-Tyne, UK)
David Hosking (Nottingham, UK)
Anne Langston (Aberdeen, UK)
Terry O’Neill (Manchester, UK)
Stuart Ralston (Edinburgh, UK)
Peter Selby (Manchester, UK)

 


     
     
Symposium Home